The Justice Department on June 23 announced its 2026 National Health Care Fraud Takedown, charging 455 defendants in connection with more than $6.5 billion in alleged false claims submitted to Medicare, Medicaid, and other federal health programs [1]. The defendants include 90 licensed physicians and other medical professionals [1]. Cases were filed across 56 federal districts in 45 states and territories, making the action one of the broadest coordinated health care fraud enforcement efforts in the department's history [1][2].
The charges rest on federal statutes governing health care fraud, wire fraud, and controlled substances distribution. Alleged schemes include billing for services never rendered, fraudulent telemedicine prescriptions, unlawful distribution of opioids, and kickback arrangements between marketers and providers [1][2]. All 50 state Medicaid Fraud Control Units participated for the first time in a national takedown of this kind, reflecting coordinated federal-state enforcement authority under the False Claims Act and related anti-kickback provisions [1][2]. Federal agencies executing the action included the FBI, the Drug Enforcement Administration, and the Department of Health and Human Services Office of Inspector General [1].
The takedown marks the first major enforcement action attributed to the DOJ's newly formed National Fraud Enforcement Division, a unit within the Criminal Division established to centralize prosecution of large-scale fraud [1]. Investigators also secured international cooperation leading to the arrest or extradition of defendants from the Philippines, Estonia, and Turkey, a dimension that prior annual takedowns have not matched in scope [1][2]. Asset seizures exceeded $182 million [1].
The political posture of the action is notable. The announcement positions the new division as operationally active within months of its formation, and the all-50-states Medicaid unit participation signals an emphasis on federal-state coordination that prosecutors and program administrators are likely to sustain through follow-on referrals. Individual district cases will proceed on independent dockets, meaning sentencing timelines will vary widely. Defendants who are licensed professionals face parallel proceedings before state medical and pharmacy boards, which can move faster than criminal adjudication [2]. The HHS-OIG has published a dedicated enforcement page listing case-specific details by district, which defense counsel and compliance officers are expected to monitor as charging documents are unsealed in the coming weeks [2].